Report reveals growing confidence in AI-driven decision-making, but highlights persistent challenges in scaling digital investments and converting innovation into measurable business value
Founded by serial entrepreneur Dinakara Nagalla, the platform enters the Indian market with 30,000 users, and 500 wellbeing professionals
Mahler brings more than 20 years of leadership experience spanning cell therapy, biopharmaceutical development, manufacturing, and global business management
Generic launch targets a US$19 million market in United States, strengthening Glenmark’s institutional and injectable product portfolio in North America
The launch event brought together policymakers, healthcare leaders, surgeons, and members of the medical fraternity to discuss the transformative role of robotic-assisted surgery
Partnership enters its ninth year after training over 2,200 young people and enabling employment for more than 1,750 beneficiaries through nursing assistant and digital skills programs
Market grows 12.1%; volume contribution improves as 9 out of 10 key therapies post double-digit growth
Approval paves the way for expansion in North America’s growing vascular access market, with innovative SlipStream technology designed to simplify catheter insertion and enhance patient care
Since 2022, we have grown threefold and our growth story is built on scale, scientific innovation and deep customer partnerships
From a $10 billion bioeconomy to over $190 billion, indigenous CAR-T therapy, and a booming startup ecosystem highlight 12 years of transformation in India’s science and technology landscape
Subscribe To Our Newsletter & Stay Updated
